Aurora Mirabile

专科:

肿瘤科

职业:

肿瘤科医生

医疗机构:

临床肿瘤科 @ 圣拉斐尔科学研究医院

语言:

您需要预约吗？

联系我们，我们将为您妥善安排。

查看医生的可预约时间

发送请求

个人简介

Aurora Mirabile 医生是米兰 IRCCS San Raffaele 医院医学肿瘤科头颈部肿瘤诊疗负责人，同时还在耳鼻喉科专科培训学校从事教学工作。

她于2006年毕业于 Milano-Bicocca 大学医学与外科学专业，并于2009年在米兰大学以优异成绩获得医学肿瘤学专科资质。

2009年至2014年期间，她在米兰国家肿瘤研究所头颈部肿瘤药物治疗单元担任医学肿瘤科医生。2015年至2017年，她在 Sant’Antonio Abate 医院（Gallarate，VA）ASST Valleolona 医学肿瘤科担任一级医疗主管，主要从事头颈部及胃肠道肿瘤诊疗工作。

自2017年起，她以自由职业顾问合同形式加入米兰 San Raffaele 医院医学肿瘤科，担任头颈部肿瘤诊疗负责人，并自2021年起担任该项目主管。

多年来，Mirabile 医生特别专注于头颈部肿瘤、循证医学、肿瘤学临床方法学以及患者生活质量。她主要治疗的疾病包括：口腔肿瘤、口咽部肿瘤（舌根、扁桃体及软腭）、鼻咽部肿瘤、鼻旁窦及鼻腔肿瘤、喉部肿瘤、下咽部肿瘤以及唾液腺肿瘤。

她还负责这些患者的诊断与治疗路径，与耳鼻喉外科医生、放疗科医生、影像科医生、核医学专家及病理科医生合作，以优化治疗方案并确保患者能够获得更加精准、专业和有效的技术与疗法。此外，她还协调多学科团队支持患者（例如营养师、老年病专家、心理医生、牙医及伤口护理专家等），以优化患者生活质量，并确保在整个治疗过程中获得必要支持。

Mirabile 医生还是多项III期临床研究的 Principal Investigator，研究内容涉及新的生物制剂及免疫治疗药物，用于局部晚期及转移性疾病，以便让患者能够获得最先进的治疗方案。

她是52篇国际及国内期刊全文论文、摘要及书籍章节的作者及共同作者；作为 Principal Investigator 和 Sub-investigator 参与了超过40项符合 GCP 标准的临床研究。Mirabile 医生还是多个国内及国际肿瘤学协会的活跃成员，包括 ESMO、AIOCC、AIOM、ECHNO、EORTC 和 NICSO。

多媒体中心

HPV infection and nose, mouth and throat cancers: what do we need to know?

出版物

最新出版物

Skeletal Muscle Depletion and Major Postoperative Complications in Locally-Advanced Head and Neck Cancer: A Comparison between Ultrasound of Rectus Femoris Muscle and Neck Cross-Sectional Imaging

Cancers (Basel). 2022 Jan 11;14(2):347. doi: 10.3390/cancers14020347.

Galli A, Colombo M. Prizio, Carrara G., Lira Luce F, Paesano PL, Della Vecchia G, Giordano L, Bondi S, Tulli M, Di Santo D, Mirabile A, et al.

What to Do and What Not to Do in the Management of Cancer Pain: A Physician Survey and Expert Recommendations

Cancer Manag Res. 2021 Jun 30;13:5203-5210.

Bossi P, Antonuzzo A, Armento G, Consoli F, Giuliani J, Giusti R, Lucchesi M, Mirabile A, Palermo L, Scagliarini S.

A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory Study

Diagnostics (Basel). 2021 May 28;11(6):979.

Corino VDA, Bologna M, Calareso G, Licitra L, Ghi M, Rinaldi G, Caponigro F, Morelli F, Airoldi M, Allegrini G, Cassano A, Ferrari D, Mirabile A, Tosoni A, Galizia D, Merlano M, Sponghini A, Moretti G, Mainardi L, Bossi P.

Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma

(HNSCC) patients. Acta Oncol. 2021 May 26:1-9.

Alfieri S, Romanò R, Bologna M, Calareso G, Corino V, Mirabile A, Ferri A, Bellanti L, Poli T, Marcantoni A, Grosso E, Tarsitano A, Battaglia S, Blengio F, De Martino I, Valerini S, Vecchio S, Richetti A, Deantonio L, Martucci F, Grammatica A, Ravanelli M, Ibrahim T, Caruso D, Locati LD, Orlandi E, Bossi P, Mainardi L, Licitra LF.

Uncommon site of metastatis and prolonged survival in patients with anaplastic thyroid carcinoma: a systematic review of the literature

Cancers (Basel). 2020 Sep 10:12(9):2585.

Mirabile A, Biafora M, Giordano L. et al.

Low skeletal muscle mass as predictor of postoperative complications and decreased overall survival in locally advanced head and neck squamous cell carcinoma: the role of ultrasound of rectus femoris muscle

[published online ahead of print, 2020 Jun 13] Eur Arch Otorhinolaryngol. 2020;10.1007/s00405-020-06123-3. doi:10.1007/s00405-020-06123-3

Galli A, Colombo M, Carrara G, Lira Luce F, Paesano PL, Giordano L, Bondi S, Tulli M, Mirabile A, De Cobelli F, Bussi M.

Metabolism and Immune Modulation in Patients with Solid Tumors: Systematic Review of Preclinical and Clinical Evidence

Cancers (Basel). 2020;12(5):E1153. Published 2020 May 4. doi:10.3390/cancers12051153

Mirabile A, Rivoltini L, Daveri E, et al.

Head and Neck Cancer: Psychological and Psychosocial Effects

The Impact of Pain- Head and Neck Cancer, 2020 – Springer.

P. Bossi, M C Merlano, M G Ghi, G RInalkdi, F Casponigro, M Airoldi, A Farnesi, A Cassano, D Ferrari, A Mirabile, A Tosoni, D Galizia, G Moretti, G Calareso, A Vingiani, F Perrone, A Falletta, LF Licitra. A single-ar, open label multicenter, phase IIIb clinical trial with nuvolumab in subjects with recurrent or metastatic platinum-refractoru squamous cell carcinoma of the head and neck. Annals of Oncology, Volume 30, Issue Supplement_5, October 2019,https://doi.org/10.1093/annonc/mdz252.032 9. CE Fundakowski ; A Mirabile

Patients Selection for Immunotherapy in Solid Tumors: Overcome the Naïve Vision of a Single Biomarker

Biomed Res Int. 2019 Apr 24;2019:9056417. doi: 10.1155/2019/9056417. eCollection 2019. Review.

Signorelli D, Giannatempo P, Grazia G, Aiello MM, Bertolini F, Mirabile A, Buti S, Vasile E, Scotti V, Pisapia P, Cona MS, Rolfo C, Malapelle U, Group IY.

Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck

Head Neck. 2019 Jan 16.

Mirabile A, Miceli R, Calderone RG, Locati L, Bossi P, Bergamini C, Granata R, Perrone F, Mariani L, Licitra L.

Prevalence, characteristics, and treatment of fatigue in oncological cancer patients in Italy: a cross-sectional study of the Italian Network for Supportive Care in Cancer (NICSO)

(Network Italiano per le Cure di Supporto in Oncologia). Support Care Cancer. 2018 Aug 6. doi: 10.1007/s00520-018-4393-9.

Roila F1, Fumi G2, Ruggeri B3, Antonuzzo A4, Ripamonti C5, Fatigoni S2, Cavanna L6, Gori S7, Fabi A8, Marzano N9, Graiff C10, De Sanctis V11, Mirabile A12, Serpentini S13, Bocci C14, Pino MS15, Cilenti G16, Verusio C17, Ballatori E18; NICSO

Predictors of Patient-Reported Dysphagia Following IMRT Plus Chemotherapy in Oropharyngeal Cancer

Dysphagia. 2018 Jun 8. doi: 10.1007/s00455-018-9913-8.

Orlandi E1, Miceli R2, Infante G2, Mirabile A3, Alterio D4, Cossu Rocca M5, et al.